QA: Clearside Biomedical Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001539029_2019_Clearside_Biomedical_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001539029, Clearside Biomedical Inc.

  xvar xval
0 AssetsCurrent 42,944,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 790,000
3 remainder_Assets 386,000
4 LiabilitiesCurrent 10,476,000
5 LiabilitiesNoncurrent 9,419,000
6 remainder_Liabilities 605,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,684,000
9 ResearchAndDevelopmentExpense 68,291,000
10 remainder_Expenses 0
11 remainder_Revenues 30,000
12 remainder_NetIncome 127,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 44,120,000
1 Liabilities 20,500,000
2 Expenses 82,975,000
3 Revenues 30,000
4 StockholdersEquity 23,620,000
5 NetIncome -82,818,000
6 ComprehensiveNetIncome -82,818,000
7 BaseVar 73,876,000
8 EconomicCapitalRatio -1.31

Edgar->Model Mapping

Feature Distribution

Change over Time